Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;40(2):190-195.
doi: 10.3760/cma.j.cn501225-20230721-00011.

[Research advances on the role of microRNA engineered exosomes in diabetic wounds]

[Article in Chinese]
Affiliations
Review

[Research advances on the role of microRNA engineered exosomes in diabetic wounds]

[Article in Chinese]
X C Jian et al. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. .

Abstract

Diabetic wounds are a common complication in patients with diabetes, which is difficult to treat. Current treatment methods for diabetic wounds include debridement, functional dressing coverage, negative pressure therapy, bone cement filling, and skin grafting, etc. MicroRNA (miRNA) engineered exosomes have shown promising potential in diabetic wound repair due to the ability to alleviate inflammation, stimulate angiogenesis, and promote collagen deposition and re-epithelialization. Related researches are being actively carred out. This paper reviews the pathophysiological characteristics of diabetic wounds, the characteristics of miRNA and exosomes, the engineering methods for exosomes loaded with miRNA, and the mechanism of miRNA engineered exosomes in promoting healing of diabetic wounds, aiming to provide a reference basis for the future clinical application of miRNA engineered exosomes in diabetic wounds.

糖尿病创面是糖尿病患者常见的并发症之一,治疗较为困难。目前,糖尿病创面的治疗方法包括清创、功能性敷料覆盖、负压治疗、骨水泥填充、皮肤移植等。微小RNA(miRNA)工程化外泌体具有减轻炎症、刺激血管生成、促进胶原沉积和再上皮化等功能,在糖尿病创面修复中展现出巨大潜力,相关研究正在积极开展。该文对糖尿病创面的病理生理特征、miRNA与外泌体的特性、外泌体负载miRNA的工程化方法和miRNA工程化外泌体促进糖尿病创面愈合的机制进行综述,以期为miRNA工程化外泌体在糖尿病创面中的临床应用提供参考依据。.

PubMed Disclaimer

Conflict of interest statement

利益冲突 所有作者均声明不存在利益冲突

Similar articles

Cited by

References

    1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Armstrong DG, Boulton A, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi: 10.1056/NEJMra1615439. - DOI - PubMed
    1. 中国医疗保健国际交流促进会糖尿病足病分会, 国际血管联盟中国分部糖尿病足病专家委员会 中国糖尿病足诊治指南. 中国临床医生杂志. 2020;48(1):19–27. doi: 10.3969/j.issn.2095-8552.2020.01.007. - DOI
    1. 海峡两岸医药卫生交流协会烧创伤暨组织修复专委会 负压伤口疗法在糖尿病足创面治疗中的应用全国专家共识(2021版) 中华烧伤杂志. 2021;37(6):508–518. doi: 10.3760/cma.j.cn501120-20210107-00010. - DOI
    1. Wei P, Zhong C, Yang X, et al. Exosomes derived from human amniotic epithelial cells accelerate diabetic wound healing via PI3K-AKT-mTOR-mediated promotion in angiogenesis and fibroblast function[J/OL]. Burns Trauma, 2020, 8: tkaa020[2023-07-21]. https://pubmed.ncbi.nlm.nih.gov/32923490/. DOI: 10.1093/burnst/tkaa020.

LinkOut - more resources